Cargando…
Treatment of pediatric antimuscarinic delirium with oral rivastigmine
Antimuscarinic drug toxicity is a common pediatric emergency, which produces central and peripheral symptoms. Treatment of agitation and hyperactive antimuscarinic delirium, with first-line agents like cholinesterase inhibitors or benzodiazepines, is imperative to prevent severe toxicity. Intravenou...
Autores principales: | Yakey, Brandtly, Vohra, Varun, Martin, Amarilis, King, Andrew M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530290/ https://www.ncbi.nlm.nih.gov/pubmed/37771682 http://dx.doi.org/10.1093/omcr/omad096 |
Ejemplares similares
-
A pilot study of rivastigmine in the treatment of delirium after stroke: A safe alternative
por: Oldenbeuving, Annemarie W, et al.
Publicado: (2008) -
Acquired Localized Hypertrichosis Induced by Rivastigmine
por: Imbernón-Moya, Adrian, et al.
Publicado: (2016) -
Risk of delirium associated with antimuscarinics in older adults: A case‐time‐control study
por: Nishtala, Prasad S., et al.
Publicado: (2022) -
Treatment of Severe Swallowing Dysfunction in Systemic Sclerosis with IVIG: Role of Antimuscarinic Antibodies
por: Mendoza, Fabian A., et al.
Publicado: (2022) -
An Atypical Cutaneous Reaction to Rivastigmine Transdermal Patch
por: Grieco, T., et al.
Publicado: (2011)